stoxline Quote Chart Rank Option Currency Glossary
  
Abbott Laboratories (ABT)
119.46  0.44 (0.37%)    02-23 16:00
Open: 119.38
High: 120.15
Volume: 4,247,975
  
Pre. Close: 119.02
Low: 118.86
Market Cap: 207,285(M)
Technical analysis
2024-02-23 4:34:44 PM
Short term     
Mid term     
Targets 6-month :  140.33 1-year :  163.91
Resists First :  120.15 Second :  140.33
Pivot price 114.12
Supports First :  113.71 Second :  109.73
MAs MA(5) :  117.4 MA(20) :  113.92
MA(100) :  104.89 MA(250) :  104.77
MACD MACD :  1.6 Signal :  1
%K %D K(14,3) :  96.2 D(3) :  92.9
RSI RSI(14): 71
52-week High :  120.15 Low :  89.66
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ ABT ] has closed It is unclear right now based on current values. 51.2% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 120.22 - 120.58 120.58 - 120.98
Low: 117.76 - 118.2 118.2 - 118.7
Close: 118.69 - 119.35 119.35 - 120.09
Company Description

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Headline News

Sat, 24 Feb 2024
Abbott Laboratories (NYSE:ABT) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

Fri, 23 Feb 2024
Options Trading Activity Indicates Lack of Confidence in Abbott Laboratories - Best Stocks

Fri, 23 Feb 2024
Abbott (ABT) Up 5.8% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Thu, 22 Feb 2024
Abbott Laboratories stock rises Thursday, still underperforms market - MarketWatch

Thu, 22 Feb 2024
What’s Next For Abbott Stock After A 6% Rise This Year? - Forbes

Thu, 22 Feb 2024
Institutional investors have a lot riding on Abbott Laboratories (NYSE:ABT) with 77% ownership - Simply Wall St

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical Devices
Shares Out 1,740 (M)
Shares Float 1,720 (M)
Held by Insiders 0.5 (%)
Held by Institutions 76.9 (%)
Shares Short 12,700 (K)
Shares Short P.Month 11,880 (K)
Stock Financials
EPS 3.25
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 21.59
Profit Margin 14.2 %
Operating Margin 17.9 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 15.3 %
Qtrly Rev. Growth 1.5 %
Gross Profit (p.s.) 0
Sales Per Share 23.05
EBITDA (p.s.) 5.7
Qtrly Earnings Growth 55.2 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 36.64
PEG Ratio 3.1
Price to Book value 5.53
Price to Sales 5.18
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android